Bioadaptives, Inc. (BDPT) Net Margin (2016 - 2026)

Bioadaptives (BDPT) posted Net Margin of 2014.62% for Q1 2026, up 74.49% sequentially from 7896.29% in Q4 2025.

Bioadaptives, Inc. (BDPT) Net Margin (2016 - 2026) Analysis & Trends

Bioadaptives has reported Net Margin for 9 years, with the latest figure at 2014.62% in Q1 2026.

Quarterly Net Margin changed N/A year-over-year to 2014.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6186.31% (up 11078998.0% YoY) and the FY2025 annual result came in at 8523.35%, down 142602.0% from the prior year.
Net Margin grew to 2014.62% in Q1 2026 per BDPT's latest filing, from 7896.29% in the prior quarter.
Over five years, Net Margin peaked at 721.06% in Q3 2023 and troughed at 27113.63% in Q2 2024.
A 5-year average of 5547.74% and a median of 4765.84% in 2023 frame the typical range for Net Margin.
The sharpest annual moves came in 2024 and 2025: Net Margin sank 2248764 bps in 2024, then jumped 2220794 bps in 2025.
Over 5 years, Net Margin stood at 973.92% in 2022, then plunged by 49 bps to 1455.24% in 2023, then slumped by 1763 bps to 27113.63% in 2024, then jumped by 71 bps to 7896.29% in 2025, then jumped by 74 bps to 2014.62% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 2014.62%, 7896.29%, and 8193.05% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Download Data